EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer

Clinical trial NCT00035100 · COMPLETED

Trial details

NCT number: NCT00035100
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasms Peritoneal Neoplasms Fallopian Tube Neoplasms

Start date: 2001-09-01
Primary completion: 2003-06-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.